Citadel Advisors
SILK

Citadel Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Citadel Advisors’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,500
Closed -$960K – 15557
2024
Q2 		$960K Sell
35,500
-63,000
-64% -$1.31M ﹤0.01% 6667
2024
Q1 		$1.8M Buy
98,500
+71,100
+259% +$1.13M ﹤0.01% 5724
2023
Q4 		$336K Sell
27,400
-93,600
-77% -$878K ﹤0.01% 8938
2023
Q3 		$1.81M Buy
121,000
+115,500
+2,100% +$2.4M ﹤0.01% 5398
2023
Q2 		$179K Sell
5,500
-15,300
-74% -$559K ﹤0.01% 10064
2023
Q1 		$814K Buy
20,800
+18,400
+767% +$900K ﹤0.01% 7235
2022
Q4 		$127K Sell
2,400
-4,400
-65% -$214K ﹤0.01% 10862
2022
Q3 		$306K Buy
+6,800
New +$292K ﹤0.01% 9538
2022
Q2 		– Sell
-23,400
Closed -$966K – 14396
2022
Q1 		$966K Buy
23,400
+8,600
+58% +$303K ﹤0.01% 7778
2021
Q4 		$631K Buy
14,800
+400
+3% +$20K ﹤0.01% 9094
2021
Q3 		$792K Sell
14,400
-3,000
-17% -$157K ﹤0.01% 8729
2021
Q2 		$833K Buy
17,400
+8,400
+93% +$428K ﹤0.01% 8835
2021
Q1 		$456K Buy
9,000
+2,500
+38% +$139K ﹤0.01% 9871
2020
Q4 		$409K Sell
6,500
-12,000
-65% -$745K ﹤0.01% 8519
2020
Q3 		$1.24M Sell
18,500
-28,400
-61% -$1.55M ﹤0.01% 5641
2020
Q2 		$1.97M Buy
46,900
+38,400
+452% +$1.47M ﹤0.01% 4618
2020
Q1 		$268K Sell
8,500
-1,200
-12% -$48K ﹤0.01% 7528
2019
Q4 		$392K Buy
+9,700
New +$340K ﹤0.01% 7186

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's SILK Position: Q3 2024 in Review

Citadel Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 285,886 shares — an estimated $7.73M sold.

Citadel Advisors first reported a position in SILK in Q2 2019 and held it in 19 quarters. The position peaked at $22.1M in Q1 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Citadel Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 285,886 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $7.73M.
  • Citadel Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
  • Citadel Advisors's Silk Road Medical, Inc. Common Stock position peaked at $22.1M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.